Global Forum for Qualified Persons for Pharmacovigilance (QPPV)

Early Bird ending in

DAYS

HOURS

MINUTES

SECONDS

Back to Agenda

Session 4: AI: More Than One Year After The ChatGPT Boom, Where Are We Now In PV?

Session Chair(s)

Gemma Jimenez Sese

Senior Director, Deputy EU QPPV

AstraZeneca, Spain

Katarzyna Swiderek, MPharm, RPh

Director, Safety Evaluation Risk Management (SERM)

GlaxoSmithKline, Poland

AI is here to stay, whilst it is still in its early days in terms of regulating its use, there is a huge opportunity to utilise it widely in PV processes starting with case processing and beyond. This year’s session will provide most recent views on this topic from regulators, reflections from the industry on how this space can effectively be regulated, as well as serve as inspiration on how and when AI and automation can become a win for small/medium size companies.

Speaker(s)

EMA On-going Activities on AI

Luis Pinheiro

European Medicines Agency, Netherlands

Senior Epidemiology Expert, RWE, Data Analytics and Methods Taskforce

Have an account?

Download registration form Register Now (Credit Card)